Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
about
Conformational flexibility of the oncogenic protein LMO2 primes the formation of the multi-protein transcription complexLYL1 degradation by the proteasome is directed by a N-terminal PEST rich site in a phosphorylation-independent manner.Friend of GATA-1-independent transcriptional repression: a novel mode of GATA-1 functionJMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia.The expansion of T-cells and hematopoietic progenitors as a result of overexpression of the lymphoblastic leukemia gene, Lyl1 can support leukemia formation.Cell-Type-Specific Effects of Silibinin on Vitamin D-Induced Differentiation of Acute Myeloid Leukemia Cells Are Associated with Differential Modulation of RXRα Levels.Prognostic Significance of the Lymphoblastic Leukemia-Derived Sequence 1 (LYL1) GeneExpression in Egyptian Patients with AcuteMyeloid Leukemia.MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.Knockdown of LYL1 impaired proliferation of CD34(+) myeloid leukemia cells.LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.
P2860
Q27681258-47855DEA-C8D6-4470-BA92-33D1A6D7951AQ34117465-A00A4146-6B3A-411A-8098-76BA103CFE2AQ35839913-CE9CB00D-17C4-4BF1-8B86-16071865998AQ36199628-B888C481-EB34-49E7-88A9-0A3039F4ABD3Q36448329-FA2F78AD-4C7E-49D1-AF5D-E6977FB7BDE1Q38969143-F4C76C3E-C517-4A51-82C3-EDADAEF30EB0Q41877761-98293642-2B22-42CE-AD72-4FF31B8BE1AFQ42352119-1500DA68-1DA7-4BA3-9D32-30A974A9E0B1Q42738559-7CD030DB-A211-431C-84DD-5FCEAFEC8976Q50066248-839F753C-80EB-412E-B358-F561D8562BF3Q50902018-43B621A9-3458-4E4F-80AA-E9EB1A9C3EF1Q51776471-B8251FC4-AB97-4892-BD15-4C2DE17F478CQ52715015-0A84356B-27B3-4CA3-B8CB-611F4B61602F
P2860
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@ast
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@en
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@nl
type
label
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@ast
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@en
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@nl
prefLabel
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@ast
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@en
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403836
P50
P577
2005-11-01T00:00:00Z
P5875
P6179
1008533171